Literature DB >> 1525326

Leukemia, lymphoma, and multiple myeloma following selected medical conditions.

M M Doody1, M S Linet, A G Glass, G D Friedman, L M Pottern, J D Boice, J F Fraumeni.   

Abstract

The role of selected prior medical conditions in the etiology of hematopoietic malignancies was examined in a case-control study of members of two regional branches of the Kaiser Permanente Medical Care Program (USA). Past history of chronic infectious, autoimmune, allergic, and musculoskeletal disorders was abstracted from medical records for leukemia (n = 299), non-Hodgkin's lymphoma (NHL, n = 100), and multiple myeloma (n = 175) cases and matched controls (n = 787). Little difference was found between cases and controls for most of the chronic conditions evaluated, including sinusitis, carbuncles, urinary tract infections, pelvic infections, herpes zoster, asthma, rheumatoid arthritis, psoriasis, bursitis, and gout. Only three statistically significant elevated risks were found, i.e., with combined disc disease myeloma among patients with prior eczema and disk and other musculoskeletal conditions, and NHL following tuberculosis. Only two of these associations showed consistent patterns by sex and geographic region (myeloma with eczema and with musculoskeletal conditions). While prior history of eczema and musculoskeletal conditions may slightly increase risk of myeloma, this study provided little if any support for an association of chronic infectious, autoimmune, allergic, and musculoskeletal conditions with subsequent occurrence of the leukemias or NHL. Additionally, these data did not support a role for chronic antigenic stimulation, as defined in previous epidemiologic studies, in the etiology of hematopoietic malignancies.

Entities:  

Mesh:

Year:  1992        PMID: 1525326     DOI: 10.1007/bf00051358

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  42 in total

1.  Epidemiology of diseases in adult males with leukemia.

Authors:  R Gibson; S Graham; A Lilienfeld; L Schuman; M Levin; M Swanson
Journal:  J Natl Cancer Inst       Date:  1976-05       Impact factor: 13.506

2.  Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire.

Authors:  R A Cartwright; P A McKinney; C O'Brien; I D Richards; B Roberts; I Lauder; C M Darwin; S M Bernard; C C Bird
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

Review 3.  The epidemiology of multiple myeloma.

Authors:  D A Riedel; L M Pottern
Journal:  Hematol Oncol Clin North Am       Date:  1992-04       Impact factor: 3.722

4.  Diagnostic x-ray procedures and risk of leukemia, lymphoma, and multiple myeloma.

Authors:  J D Boice; M M Morin; A G Glass; G D Friedman; M Stovall; R N Hoover; J F Fraumeni
Journal:  JAMA       Date:  1991-03-13       Impact factor: 56.272

5.  Association of non-Hodgkin's lymphoma with rheumatoid arthritis.

Authors:  N Pearce; M Porta
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

6.  Prolonged adjuvant stimulation in germ-free BALB-c mice: development of plasma cell neoplasia.

Authors:  K R McIntire; G L Princler
Journal:  Immunology       Date:  1969-09       Impact factor: 7.397

7.  Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis.

Authors:  H A Isomäki; T Hakulinen; U Joutsenlahti
Journal:  J Chronic Dis       Date:  1978

8.  Yorkshire Case Control Study of Leukaemias and Lymphomas Parallel Multivariate Analyses of Seven Disease Categories.

Authors:  P A Mckinney; F E Alexander; B E Roberts; C O'brien; C C Bird; R A Cartwright
Journal:  Leuk Lymphoma       Date:  1990

9.  Chronic immune stimulation is required for Moloney leukaemia virus-induced lymphomas.

Authors:  J C Lee; J N Ihle
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

10.  Antigenic stimulation and the occurrence of multiple myeloma.

Authors:  T D Koepsell; J R Daling; N S Weiss; J W Taylor; A F Olshan; J L Lyon; G M Swanson; M Child
Journal:  Am J Epidemiol       Date:  1987-12       Impact factor: 4.897

View more
  29 in total

Review 1.  Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Jill Koshiol; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-07       Impact factor: 9.941

2.  Association of asthma with the risk of acute leukemia and non-Hodgkin lymphoma.

Authors:  Min-Hang Zhou; Qing-Ming Yang
Journal:  Mol Clin Oncol       Date:  2015-05-11

Review 3.  The role of immunosuppression in lymphoma formation.

Authors:  I Penn
Journal:  Springer Semin Immunopathol       Date:  1998

Review 4.  Insight into rheumatological cause and effect through the use of Mendelian randomization.

Authors:  Philip C Robinson; Hyon K Choi; Ron Do; Tony R Merriman
Journal:  Nat Rev Rheumatol       Date:  2016-07-14       Impact factor: 20.543

Review 5.  Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?

Authors:  L Georgescu; S A Paget
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

6.  Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China.

Authors:  W Zheng; M S Linet; X O Shu; R P Pan; Y T Gao; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

7.  Subcutaneous T-cell lymphoma in a patient with rheumatoid arthritis not treated with cytotoxic agents.

Authors:  Y Levy; J George; A Abraham; A Afek; A Livneh; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

8.  Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

Authors:  Linda Morris Brown; Gloria Gridley; David Check; Ola Landgren
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

9.  Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

Authors:  Claire M Vajdic; Michael O Falster; Silvia de Sanjose; Otoniel Martínez-Maza; Nikolaus Becker; Paige M Bracci; Mads Melbye; Karin Ekström Smedby; Eric A Engels; Jennifer Turner; Paolo Vineis; Adele Seniori Costantini; Elizabeth A Holly; Eleanor Kane; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Brian C-H Chiu; Luigino Dal Maso; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Wendy Cozen; Andrew E Grulich
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

10.  Common community-acquired infections and subsequent risk of multiple myeloma: a population-based study.

Authors:  Charlene M McShane; Liam J Murray; Eric A Engels; Ola Landgren; Lesley A Anderson
Journal:  Int J Cancer       Date:  2013-10-12       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.